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Abstract
Background: Gender-related differences in incidence of arterial thrombosis have been a focus of
interest for years. The platelet integrin αIIbβ3 is primarily responsible for the interaction between
platelets and fibrinogen and consecutive thrombus growth. In this study, we evaluated platelet
adhesion onto immobilized fibrinogen under venous and arterial flow conditions in men and
women.
Methods:  Platelets in whole anticoagulated blood were labelled with the fluorescence dye
Mepacrine and perfused through the rectangular flow chamber over glass cover slips coated with
fibrinogen (shear rates of 50 s-1, 500 s-1 and 1500 s-1). A fluorescence laser-scan microscope was
used for visualisation and quantification of platelet adhesion at 15 seconds, 1 and 5 minutes after
the start of perfusion.
Results: During perfusion, the platelet adhesion linearly increased in regard to exposition time and
shear rate. After five minutes of perfusion the platelet adhesion onto immobilized fibrinogen
showed no significant gender related difference, neither at 50 s-1 nor at 500 s-1 and 1500 s-1 (p >
0.05), respectively. No significant difference in platelet adhesion onto immobilized fibrinogen, in
regard to the menopausal status, was either observed (p > 0.05).
Conclusion: In our in vitro experimental system, hormonal differences between men and women
did not influence platelet adhesion onto immobilized fibrinogen, neither under venous nor under
arterial rheological conditions.
Background
Ischemic heart and cerebrovascular disease are leading
causes of morbidity and mortality in the western world
and are steadily increasing incidence in the third world as
well [1,2]. Epidemiological studies [3] indicate that these
diseases result from complex interactions between genetic
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susceptibility factors, chronic environmental influences
(e.g. hormonal imbalance, smoking, obesity) and estab-
lished, intercurrent disorders (e.g. diabetes, hypertension,
dyslipidemia, or hyperhomocysteinemia). The most dev-
astating complication of these disorders is acute myocar-
dial infarction or stroke resulting from the formation of
occlusive thrombus at the site of ruptured atherosclerotic
plaque [1-4]. Platelet-dependent thromboembolism is an
underlying mechanism of arterial thrombosis and the crit-
ical role of platelets in this process is now widely accepted
[1,5]. Its participation in the arterial thrombosis is cen-
tered on their adhesive properties and their ability to
respond to stimuli with rapid activation and, as end effect,
aggregation [5,6].
It has been well known that the incidence of arterial
thrombotic events in women is generally lower compared
to that in men. It was our initial point to speculate about
beneficial effects of female sexual hormons in regard to
the incidence of arterial thrombosis and one of the rea-
sons for non-critical and non-selective inducing estrogen
replacement therapy (ERT). Although several studies have
demonstrated that postmenopausal women who take ERT
show decreased incidence of arterial thrombosis com-
pared to those without ERT [7], there has been no clear
epidemiological evidence for decrease in a thrombotic
risk. All these reports of beneficial effects of estrogen are
based on the retrospective studies and a small number of
controlled clinical trials. Recently conducted clinical trials
have shown ERT could also be associated with adverse
arterial vascular events [8-10]. It seems that risk and ben-
efit effect of estrogen is also dose dependent. However, the
possible mechanism and efficiency of estrogen mediated
antithrombotic or prothrombotic action is still a contro-
versial issue.
Arterial thrombosis is initiated by platelet activation, but
the in-vivo effects of estrogens on a platelet function have
not been well understood. Platelet membrane integrin
αIIbβ3 (glycoprotein GP IIb–IIIa) has an important role
in platelet adhesion and aggregation through binding of a
variety of circulating and immobilized ligands including
fibrinogen under different shear stress conditions
[5,6,11,12]. However, when platelets are activated by var-
ious stimuli, the platelet αIIbβ3 undergoes a conforma-
tional change and provides a high-affinity binding site for
a soluble fibrinogen. The fibrinogen acts as a bridging
molecule between pairs of αIIbβ3 molecules in adjacent
activated platelets [5,6,13]. On the other side, the interac-
tion between immobilized fibrinogen and platelets does
not require previous platelet activation or conformational
changes of platelet αIIbβ3 and has been shown to occur
even in the presence of platelet inhibitors [5]. An immo-
bilized fibrinogen can be found on the injured surface of
vascular endothelium, atherosclerotic plaques and vascu-
lar prostheses, where it is the major ligand mediating
platelet thrombus growth on artificial surfaces [5,6]. This
study, conducted under strictly controlled experimental
venous and arterial environmental conditions, was under-
taken to determine whether platelet adhesion in healthy
individuals, mediated through the integrin αIIbβ3, was
depending on the gender-related hormonal status.
Methods
The study was conducted on 28 age-matched and healthy
blood donors (14 women and 14 men). The mean age
was 44 ± 12 years. In the preceding 14 days none of
donors had taken any medication. None of enrolled
women was on oral contraceptives or ERT and had no
proven anamnestic evidence of hormonal disbalance. In
each participant screening tests of coagulation, factors of
coagulation and different biochemical parameters (Table
1) were assessed.
Excessive smokers, overweight donors, donors with a fam-
ily history of neoplastic, arterial or venous vessels disease
were excluded from the study. Experimental protocols
were reviewed and approved by the local ethics committee
and meet the standards of the Declaration of Helsinki.
Blood preparation
Blood taken from the cubital vein was immediately anti-
coagulated with PPACK (D-Phenylalanyl-L-prolyl-L-
arginine chloromethyl ketone) at a final concentration of
40 µM. Platelets were labelled with the fluorescence dye
Mepacrine (quinacrine dihydrochloride, final concentra-
tion 10 µM; Sigma Chemical, 60 min at 37°C). The dye
immediately accumulates in the delta granules of platelets
without influencing a platelet physiology [6]. Blood was
used within two hours of its withdrawal.
Binding specificity of platelets to immobilized fibrinogen
was tested with two additional experimental designs. In
the first experimental set, a specificity of platelet adhesion
onto immobilized fibrinogen was tested in flow experi-
ments using glass coverslips co-coated with bovine serum
albumin (BSA, 5 µg/mm2, n = 3). In the second set of
experiments (n = 3) a blood was additionally incubated
with Abciximab (c7E3, 4 µg/mL for 10 min, 37°C) and
perfused over fibrinogen coated coverslips. c7E3 Fab is a
chimeric human/mouse Fab fragment derived from the
murine monoclonal 7E3 antibody (c7E3, Centocor Inc.
Leiden, Niederland) that binds selectively to the αIIbβ3
[14].
Screening parameters and factors of coagulation were
assessed with commercial hemostatic high-speed analyz-
ers and kits for clotting as well as chromogenic and immu-
nologic coagulation assays (BCT®  and BCS®, Dade-
Behring, Marburg Germany). Both systems measure coag-Thrombosis Journal 2007, 5:5 http://www.thrombosisjournal.com/content/5/1/5
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ulation capabilities of plasma from blood collected using
a 3.8% sodium citrate as anti-coagulant.
Genotyping
All subjects were genotyped for the β3 polymorphism of
αIIbβ3 (Leucine-Proline substitution at amino acid 33) by
polymerase chain reaction amplification of genomic DNA
followed by restriction enzyme digestion (polymerase
chain reaction-restriction fragment length polymor-
phism), as published previously [15].
Preparation of fibrinogen-coated cover slips
Suspensions of human fibrinogen (Sigma-Aldrich) were
prepared as previously described [6]. Glass cover slips (24
× 50 mm) were coated with 50 µl of fibrinogen solution
(2,5 mg/mL). The cover slip was placed in a humid envi-
ronment (60 min at 37°C) to allow the protein to adhere
to the glass surface. The coated cover slips were rinsed
with 10 mL of 50 mmol/L phosphate buffered saline (pH
7.35) to remove non-adherent fibrinogen and were placed
into the flow chamber. Fibrinogen density on the glass
surfaces was calculated to be 0.1 µg/mm2. For control
experiments, three cover slips were coated with bovine
serum albumin. Glass surfaces density of bovine serum
albumin was calculated to be of 5 µg/mm2.
Flow chamber and laser-scan microscopy
Platelet adhesion rate onto fibrinogen-coated glass cover
slips was conducted in the rectangular flow chamber [16]
under linear shear rate of 50 s-1, 500 s-1 and 1500 s-1,
respectively.
One side of the parallel flow chamber was formed by a
fibrinogen coated glass cover slip with a flow path height
of 50 µm, determined by Teflon gasket. Assembled flow
chambers were filled with phosphate buffered saline (pH
7.35). According to the Newtonian fluid axiom, a shear
stress is constant and dependent on the flow rate. Shear
rate of 50 s-1 represents venous environment, share rate of
500 s-1 mimics wall shear rate of larger arteries; shear rate
of 1500 s-1 represents a typical arteriolar shear rate as well
as shear rate in moderate arterial stenosis [17]. An epiflu-
orescence laser-scan microscope (Axiovert 100 M, Carl-
Zeiss, Jena, Germany) allowed a real-time visualisation of
labelled platelets during perfusion through the chamber.
To assess the time-course of platelet adhesion, series of
images (five images per series, 0,7 s per image) were
recorded at 0, 1 and 5 minutes. The zero time point repre-
sents 15 seconds after the start of perfusion (Perfusor, B.
Braun, Meslingen, Germany). Image analysis was per-
formed using the ImageJ software (version 1.26t, NIH,
Table 1: Descriptive statistical data related to participant's gender, age, haemostaseology and biochemical parameters
Parameter Female Male p
Age 46 ± 12 41 ± 10 ns
Htc 37 ± 3 41 ± 2 0.014
Fibrinogen 285 ± 71 231 ± 60 ns
FII 146 ± 20 124 ± 20 0.037
FV 141 ± 22 125 ± 27 ns
FVII 140 ± 46 116 ± 32 ns
FVIII 174 ± 109 119 ± 34 ns
VWF-Activity 179 ± 105 172 ± 103 ns
VWF-Ag 164 ± 69 133 ± 74 ns
FIX 126 ± 24 116 ± 27 ns
FX 138 ± 34 122 ± 24 ns
FXI 111 ± 25 101 ± 32 ns
FXII 113 ± 16 98 ± 8 0.029
FXIII 127 ± 16 108 ± 19 0.04
Protein C 120 ± 21 112 ± 16 ns
Protein S 92 ± 18 105 ± 15 ns
Plasminogen 110 ± 14 108 ± 12 ns
Trigliceride 156 ± 99 197 ± 110 ns
Cholesterol 199 ± 36 190 ± 37 ns
LDL 124 ± 28 108 ± 25 ns
HDL 52 ± 18 39 ± 10 ns
CRP 0.6 ± 0.5 0.5 ± 0.6 ns
Fe 60 ± 34 101 ± 49 ns
Ferritine 10 ± 7 26 ± 19 ns
Homocysteine 9 ± 4 10.5 ± 4 ns
ATIII 104 ± 8 99 ± 7 ns
Thr 304 ± 50 243 ± 51 0.019
p = level of statistical significance (two-side)
ns = no significanceThrombosis Journal 2007, 5:5 http://www.thrombosisjournal.com/content/5/1/5
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USA). This program allows evaluation of platelet-surface
interaction, consecutive aggregation and evaluation of
thrombus generation at one exactly defined area in each
image. A single frame image corresponds to the area of
980 × 980 µm. The stable attached platelets (expressed as
fluorescence) were defined as those, which remain at their
initial adhering position in the first and second image
(time frame of 0.7 sec). Platelets were considered to move
on the surface when exhibiting spatial displacement
greater than a diameter of one platelet. To estimate the
motion, a series of 5 images (time frame 0.7 sec) at one
time point was made. Using ImageJ software, images were
digitalized and a threshold was applied to distinguish
platelet from background. The first two consecutive
frames in a series were superimposed using the logical
AND function. The resulting image represented only the
overlapping areas of single platelets at two different time
points.
Calculations and statistics
Data in this study are given as mean values ± SD. Absolute
fluorescence was expressed as arbitrary units (pixel units)
and represents sum of fluorescence of each thrombus or
individual adherent platelet in one defined area. Only
platelets showing a stable adherence during one series of
image were taken into calculation. Platelet adhesion was
calculated using the logic function of the applied software
(ImageJ) and represents stable adhesion of platelets
between the first and second image. To reduce the influ-
ence of inter-individual variation, data were normalized
(absolute fluorescence recorded after five minute of per-
fusion was divided by the recorded fluorescence after one
minute) and expressed as a relative adhesion. The relative
adhesion represents an increase of absolute fluorescence
as a function of time.
Differences between experimental groups were tested by
Student's t-test (two-sided). Regression analyses were
based on individual measurements using Spearman's
rank correlation coefficient. Statistical analyses were per-
formed using SPSS for Windows, version 6.0.1. P-value of
less than 0.05 (two-sided) was taken to indicate a signifi-
cant difference.
Results
A specificity of binding of platelets to immobilized fibrin-
ogen in experimental in vitro system was tested with
blood preincubated with Abciximab. A perfusion of five
minutes (1500 s-1) of Abciximab preincubated blood over
fibrinogen-coated cover slips showed no significant
adherence of platelets (absolute fluorescence of stable
adherent platelets: 168 U ± 35 U vs. 50535 U ± 21552 U
in control experiments, p < 0.05). Similarly, perfusion
over BSA-coated glass cover slips falled to show significant
platelet adherence.
The baseline characteristics of the study participants are
summarized in the Table 1 Age average was 44 ± 12 years
and did not significantly differ between men and women
(41 ± 10 vs 46 ± 12 years, p > 0.05), respectively. Biochem-
ical parameters and factors of coagulation were within the
normal range in all participants. Men showed a signifi-
cantly higher value of haematocrit and women higher
platelet count. A significant difference between men and
women was observed for Fll, FXII and FXIII. Additional
analysis indicated that these differences did not influ-
enced platelet adhesion onto immobilized ligand. All
other parameters of plasmatic haemostasis as well as bio-
chemical parameters did not differ significantly.
During the perfusion, a continous increase in platelet
adhesion on fibrinogen-coated surfaces, in function of
time and in shear rates, was observed. At shear rate of 50
s-1, platelet adhesion from 15 sec to 5 minutes increased
3.8-fold (from 2686 ± 1606 U to 10344 ± 4846 U), at 500
s-1 11-fold (from 3417 ± 1623 U to 38227 ± 16032 U)
and at 1500 s-1 platelet adhesion increased 17-fold (from
2948 U ± 1585 U to 50535 U ± 21552 U), respectively.
Parameters of plasmatic haemostasis as well as other bio-
chemical parameters, which were in the normal range, did
not correlate with the platelet adhesion. Spearman's cor-
relation coefficients between platelet adhesion and exam-
ined variables were not significant (p > 0.05). After 5
minutes of perfusion, an analysis of the platelet adhesion
onto the immobilized fibrinogen, expressed as absolute
fluorescence, showed no significant difference related to
the gender, neither at 50 s-1 nor at 1500 s-1, p > 0.05.
Descriptive statistical data of platelets adhesion in regards
to the gender and shear rate are presented in the Table 2.
Taking into consideration that platelet adhesion and
platelet detachment after initial adhesion is a dynamic
process, dependent from shear rate and perfusion time
and to avoid inter-individual variation data were normal-
ized (see Statistics).
The results of statistical evaluation of normalized data at
typical venous (50 s-1) and arterial (1500 s-1) rheological
conditions was shown in the Table 3. A growth of stable
adherent platelets was expressed as relative adhesion and
evaluated in two phases, initial and late. The initial phase
represents growth of stable adherent platelets within first
45 sec of perfusion. The late phase represents growth of
stable adherent platelets between first and fifth minute of
perfusion. Platelet relative adhesion showed slightly
higher trend at both shear conditions and in both time
frames, in men compared to women (in contrast to the
trend observed when expressed as an absolute fluores-
cence). This difference showed no statistical significance
(p > 0.05).Thrombosis Journal 2007, 5:5 http://www.thrombosisjournal.com/content/5/1/5
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However, in our study, platelet adhesion did not exhibit a
significant difference between men and women (p >
0.05.), neither expressed as an absolute adhesion nor
expressed as a relative adhesion. Further evaluation
showed no significant relationship between examined
variables (see Table 1), neither in men nor in women.
None of indicated parameters significantly correlated with
platelet adhesion.
Nevertheless, no significant correlation was found
between the platelet adhesion and age, when related to
gender (p > 0.05).
Taking into consideration expected significant differences
in hormonal status between pre- and postmenopausal
women, further statistical evaluation was focused on these
two subgroups. A relationship between platelet adhesion
in all examined shear rates in pre- and postmenopausal
women are summarized in the Figure 1, showing platelet
adhesion expressed as the absolute fluorescence. In the
Figure 1, a platelet adhesion at typical venous (50 s-1) and
arterial (500 s-1 – 1500 s-1) shear rates at three different
time points (15 sec, 1 min and 5 min), in pre- and post-
menopausal women, was presented. At all shear rates and
at each time point (excluded 15 sec at 50 s-1), one slightly
higher platelet adhesion was observed in postmenopausal
women, without statistical significance. To further charac-
terize these subgroups, all parameters presented in the
Table 1 were evaluated. No significant difference between
examined parameters was observed in regard to the men-
opausal status. Sperman's correlation coefficient between
platelet adhesion and each parameter was tested and did
not differ significantly, p > 0.05.
Experiments with immobilized collagen were conducted
together with experiments with fibrinogen (data are not
showed) and the relationship between gender related
platelet adhesion onto immobilized collagen in regard to
the shear rate and time of perfusion was carefully evalu-
ated. Between males and females, neither significant dif-
ference nor constant trend could be found in regard to the
platelet adhesion. The analysis of normalized data obtain
similar results.
Discussion
After the menopause, the risk of cardiovascular disease in
women increases to equal the risk in men, which makes a
rationale for implementation of estrogen replacement
therapy (ERT). Paradoxically, the use of estrogen itself
could also be associated with a thromboembolic disease
Table 3: Relative platelet adhesion onto immobilized fibrinogen related to the gender and shear rate.
Gender R. a. 50 s-1 R. a. 1500 s-1
initial late initial Late
Male 4.72 ± 2.05 1.94 ± 1.31 5.39 ± 2.40 4.09 ± 1.40
Female 3.02 ± 2.15 1.60 ± 0.39 4.56 ± 1.44 3.85 ± 1.31
R.a. (Relative adhesion) = absolute fluorescence recorded after one minute of perfusion was divided by fluorescence recorded 15 sec after start of 
perfusion (initial). Absolute fluorescence recorded after five minute of perfusion and divided with fluorescence recorded one minute after start of 
perfusion was marked as late.
Table 2: Platelet adhesion (mean ± SD) onto immobilized fibrinogen expressed as absolute fluorescence (AU) related to the gender, 
shear rate and perfusion time.
Shear rate and perfusion time Platelet adhesion, AU
venose shear rate, 50 s-1 males Females
15 sec 2408 ± 1697 2965 ± 1537
1 min 5857 ± 2581 7235 ± 3387
5 min 9364 ± 4588 11324 ± 5114
arterial shear rate 500 s-1
15 sec 3426 ± 1744 3408 ± 1578
1 min 9949 ± 3580 12915 ± 8963
5 min 31980 ± 11246 44474 ± 18095
arterial shear rate 1500 s-1
15 sec 2503 ± 1227 3392 ± 1826
1 min 12015 ± 4571 14161 ± 5018
5 min 47665 ± 18504 53404 ± 24797Thrombosis Journal 2007, 5:5 http://www.thrombosisjournal.com/content/5/1/5
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in women on oral contraception as well as in men treated
with diethylstilbestrol for prostate cancer [18,19].
Although the estrogen has been clinically available for
more than six decades, there has been some confusion
defining the risks and benefits of menopausal ERT [8-10].
Reagrding the central role of platelets in arterial thrombo-
sis, it was hypothesized that a hormonal status could have
a significant impact on platelet adhesion. Following the
observation of gender-dependent difference in incidence
of arterial thrombosis, it was of interest to evaluate
whether platelet adhesion under dynamic rheological
condition is gender-related or not. However, in our study,
platelet adhesion did not exhibit a significant difference
between men and women (p > 0.05.), neither expressed as
an absolute adhesion nor expressed as a relative adhesion.
As shown in the results, in experiments with immobilized
fibrinogen, women surprisingly showed consistently
higher adherence at each shear rates and at each time
point but without statistical significance (Table 2). This
difference was constant under venous flow conditions (50
s-1, average 22%) and continuously declined along the
perfusion time under arterial flow conditions (at 15 sec
25% and at 5 min 11%). Postmenopausal women
showed a slightly higher platelet adhesion compared to
premenopausal but without statistical significance. No
significant correlation was found either between platelet
adhesion and age, related to gender either.
In two very interesting studies, Miller et al. explored the
adhesive properties of platelet under static and dynamic
flow condition in regard to the gender and menopausal
status [20,21]. In static experiments the authors found out
that platelet from women showed a higher adhesion activ-
ity than those in men. This difference increased in post-
menopausal women. Simultaneously, women on ERT
showed a significantly increased platelet adhesion rate
compared to the premenopausal or postmenopausal
women without ERT. In contrast to static experiments, in
the flow studies conducted at 25 s-1 (extreme low flow)
with platelets ex-vivo preincubated with estrogen, a
decreased rate of platelet adhesion onto fibronectin was
observed [20].
Boudoulas et al [22] tried to explain this controversy of
ERT indicating that the benefit of estrogen could be
impacted in regard to the HPA-1 polymorphism. In the
aggregation study, the author described that only platelets
with HPA-1b allele had shown the benefits of estrogen
supplementation (reduced aggregation).
These findings could not be confirmed in our study.
Firstly, we did not found any significant difference in
platelet aggregation in regard to the HPA-1 polymor-
phism and secondly, no significant difference in platelet
adhesion was observed between women and men in
regard to the HPA-1 polymorphism neither at venous nor
at arterial flow conditions.
Antoher possible explanation was recently given by Tong
et al [23]. The author reported that reduction activity of
estrogen sulfotransferase (EST), due to increasing estrogen
concentration and its bioavilability induce prothrombotic
state. In animal model with generated EST knockout mice
(Sult 1-/-) a significantly higher incidence of placental
thrombosis and spontaneous fetal loss, caused by an
estrogen excess, was observed. The additional analysis of
knockout mice showed induced focal (placental) tissue
factor expression as well as increased level of procoagu-
lant factors VII, X, XII and XIII. This phenomenom was
abolished through administration of low molecular
weight heparin and/or related antiestrogen substance. It
seems that this prothrombotic effect is restricted to the
venose thrombosis, while platelets reactivity was only
moderate enhanced.
Conslusion
Platelet adhesion onto immobilized fibrinogen under
arterial and venous in-vitro flow conditions did not
exhibit a significant difference between men and women.
Platelet adhesion onto immobilized fibrinogen, expressed as  absolute fluorescence in pre- and postmenopausal women (n  represents the number of tested subjects) Figure 1
Platelet adhesion onto immobilized fibrinogen, expressed as 
absolute fluorescence in pre- and postmenopausal women (n 
represents the number of tested subjects). Platelet adhesion 
at typical venous (50 s-1) and arterial (500 s-1 – 1500 s-1) 
shear rates was tested at three different time points (15 sec, 
1 min and 5 min). At each time point of perfusion a stack of 5 
images was collected and analyzed. Finally 42 perfusion 
experiments were conducted and 630 images were analyzed.Publish with BioMed Central    and   every 
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Platelet adhesion between women and men did not differ
significantly with regard to the HPA-1 polymorphism.
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